Usman Sumo Friend Tambunan

usman2 (2)


NIP: 195304271979031001
Google Scholar: (Click Here)
Scopus Author ID56288932400

Division: Biochemistry

Title: Professor of Biochemistry


Peptide-based Drug Design

Contact Information
Office Bioinformatics Lab, G Building, Level 1, FMIPA UI
Phone +6221-7270027
Ph.D., Chemistry, Tohoku University, Japan, 1986
M.Sc., Chemistry, Tohoku University, Japan, 1983
B.Sc., Chemistry, University of Indonesia, 1978
Research Interest
  • Drug and vaccine design for avian influenza (H5N1, H1N1, H7N9), Ebola virus, dengue virus, and HPV (cervical cancer).
  • Enhancing enzyme activities for industrial application.
  • Peptide-based compounds in enhanced drug delivery.
  • Bioinorganic chemistry in complex living system.
Short Biography

Usman Sumo Friend Tambunan is Professor of the Department of Chemistry, Faculty of Mathematics and Natural Science, Universitas Indonesia since 1997. He earned his Dr. degree in Chemistry from Tohoku University, Japan in 1986 under Prof. Sho Ito supervision with dissertation title of “Synthetic Studies on Polycyclic Terpenoids.(-)-Vitrenal and (±)-Lauren-1-ene”. Afterward, he carried out postdoctoral research at Kansas University, Battelle Memorial Institute, Colombus, Ohio, USA and in Taiwan to study pharmaceutical biotechnology. Since then, he has been a lecturer for Organic Chemistry and Biochemistry at Universitas Indonesia. He has been appointed to several positions at Universitas Indonesia, such as Vice Dean I of Faculty of Mathematics and Natural Science (2001-2004) and Chief of Professor Council at Faculty of Mathematics and Natural Science (2007-2015). Additionally, he also worked as Senior Scientist at Badan Pengkajian dan Penerapan Teknologi (BPPT), Energy Resources Division (1986-1993). Currently, he also served as the editor of several prestigious journals, such as Asian Journal of Biological Sciences, International Journal of GEOMATE, Open Biochemistry Journal and Biochemistry Insight. Moreover, he has been selected as the Associate member of Institute of Integrative Omics and Applied Biotechnology (IIOAB).

Prof. Tambunan research interests focus on drug and vaccine design using computational method (in silico approach) for avian influenza (H5N1, H1N1, H7N9), Ebola virus, dengue virus, and cervical cancer. His research includes the development of natural products (such as flavonoids and stilbenoids), cyclic peptides, and fragment-based drug design to find better drug candidate to combat these diseases. Moreover, he is also specialized in enzyme stability and bioinorganic chemistry studies of the ligand-enzyme complex as well. His research has been funded by Ministry of Research Technology and Higher Education (through Penelitian Unggulan Perguruan Tinggi since 2015, and Hibah Riset Utama BOPTN from 2014-2015) and Universitas Indonesia (through Publikasi Terindeks Internasional Untuk Tugas Akhir Mahasiswa UI since 2016).

For his achievement and work at Universitas Indonesia, he has been rewarded with several prestigious awards, such as Satya Lencana (30 Years of Dedication) in 2010 and 3rd Best Professor at Universitas Indonesia in 2009.

Honor & Awards
Satya Lencana (30 Years of Dedication), 2010, Republik Indonesia, Indonesia

Exemplary Lecturer (1989-1990), 1990, Faculty of Mathematics and Natural Science, Universitas Indonesia, Indonesia

3rd Best Researcher in Science and Technologies, 2008, Universitas Indonesia, Indonesia.

3rd Best Researcher in Science and Technologies, 2009, Universitas Indonesia, Indonesia.

3rd Best Professor, 2009, Universitas Indonesia, Indonesia.

Selected Publication, Patents & Copyrights
Patents & Copyrights
  • In silico Design of Dengue Tetravalen Peptide Vaccine by using protein backbone Capsid DENV-2. Registration Number: C00201100849 / 056795.2012
  • In silico Design of Indonesian Avian Influenza A subtype H5N1 DNA Vaccine by using Conserved Region Matrix 2, Haemagglutinin, and Neuraminidase. Registration Number: 041970. 20093.
  • In silico Design of Indonesian Avian Influenza A subtype H5N1 DNA Vaccine by using Conserved Region Haemagglutinin. Registration Number: 041971. 2009
  • In silico Design of Plasmid Vector and Host for Cervical Cancer Vaccine based on Capsid L1 Protein by using Epitope Prediction of Hidden Markov Model and Artificial Neural Network. Registration Number: C00200801013. 2008
  • Tambunan, U. S. F., Alkaff, A. H., Nasution, M. A. F., Parikesit, A. A., and Kerami, D. (2017) “Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of n-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis” J. Mol. Graph. Model. 74: 366–378.
  • Tambunan, U. S. F., Nasution, M. A. F., Azhima, F., Parikesit, A. A., Toepak, E. P., Idrus, S., and Kerami, D. (2017) “Modification of S-adenosyl-L-homocysteine as inhibitor of nonstructural protein 5 methyltransferase dengue virus through molecular docking and molecular dynamics simulation” Drug Target Insights. 11: 1–14.
  • Toepak, E. P., and Tambunan, U. S. F. (2017) “In silico design of fragment-based drug targeting host processing α-glucosidase I for dengue fever” IOP Conf. Ser. Mater. Sci. Eng. 172: 1–10.
  • Zahroh, H., Ma’rup, A., Tambunan, U. S. F., and Parikesit, A. A. (2016) “Immunoinformatics approach in designing epitope-based vaccine against meningitis-inducing bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b)” Drug Target Insights. 10: 19–29.
  • Tambunan, U. S. F., Parikesit, A. A., Ghifari, A. S., and Satriyanto, C. P. (2015) “In silico identification of 2-oxo-1,3-thiazolidine derivatives as novel inhibitors candidate of class II histone deacetylase (HDAC) in cervical cancer treatment” Arabian J. Chem.
  • Tambunan, U. S. F., Zahroh, H., Parikesit, A. A., Idrus, S., and Kerami, D. (2015) “Screening analogs of β-OG pocket binder as fusion inhibitor of dengue virus 2” Drug Target Insights. 9: 33–49.
  • Tambunan, U. S. F., Parikesit, A. A., Dephinto, Y., and Sipahutar, F. R. P. (2014) “Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme” Acta Pharm. 64: 157–172.
  • Bakri, R., Parikesit, A. A., Satriyanto, C. P., Kerami, D., and Tambunan, U. S. F. (2014) “Utilization of boron compounds for the modification of suberoyl anilide hydroxamic acid as inhibitor of histone deacetylase class II Homo sapiens Advances in Bioinformatics. 7: 1–10.
  • Tambunan, U. S. F., Bramantya, N., and Parikesit, A. A. (2011) “In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)” BMC Bioinformatics. 12(Suppl 13): 1-15